HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control.

Fiche publication

Date publication

août 2022

Journal

Cardiovascular diabetology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DUVILLARD Laurence , Pr VERGES Bruno , Mr MONIER Serge

Tous les auteurs :
Denimal D, Monier S, Simoneau I, Duvillard L, Vergès B, Bouillet B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35962339

Résumé

Reduced cholesterol efflux capacity (CEC) of HDLs is likely to increase cardiovascular risk in type 1 diabetes (T1D). We aimed to assess whether improvement of glycemic control in T1D patients is associated with changes in CEC in relation with changes in carbamylation of HDLs.